Several randomized trials have demonstrated the efficacy of drug-eluting stents (DES) in reducing restenosis and the need for target vessel revascularization (TVR) in comparison to bare metal stents (BMS).1-3 Patient and lesion subsets...
Several randomized trials have demonstrated the efficacy of drug-eluting stents (DES) in reducing restenosis and the need for target vessel revascularization (TVR) in comparison to bare metal stents (BMS).1-3 Patient and lesion subsets...
Several randomized trials have...